We help investors understand market behavior through structured insights on earnings, valuation, and sector trends.
Oncolytics Biotech Inc. Common Shares (ONCY) is trading at a current price of $0.87 as of 2026-04-29, marking a -3.27% move in the current trading session. This analysis explores key technical levels, recent market context, and potential price scenarios for the clinical-stage biotech stock, which focuses on developing oncology therapeutic candidates. There are no material company-specific news releases driving the day’s price action, so investors are closely watching near-term support and resist
How does Oncolytics (ONCY) reward shareholders? (Technical Weakness) 2026-04-29 - Composite Profile
ONCY - Stock Analysis
3304 Comments
1188 Likes
1
Kiaansh
Senior Contributor
2 hours ago
This feels like a plot twist with no movie.
👍 121
Reply
2
Juliaanne
Power User
5 hours ago
Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
👍 274
Reply
3
Meril
Active Contributor
1 day ago
So much creativity in one project.
👍 193
Reply
4
Manuelito
Community Member
1 day ago
Who else is in the same boat?
👍 141
Reply
5
Alnita
Daily Reader
2 days ago
Missed it… oh well. 😓
👍 33
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.